Sami Kalevi Kilpinen

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Corero Network Security, Inc. develops network security and intrusion prevention software solutions. The firm offers SmartWall network threat defense appliance that eliminates cyber threats in real-time; SmartWall network forensics appliance that provides visibility into attacks; and SmartWall network bypass appliance that eliminates Internet downtime in case of power or equipment failures, or during planned maintenance or equipment upgrade window the company was founded by Krishna Narayanaswamy, Barry Spinney and Caryz Robinson in 1997 and is headquartered in Hudson, MA.

Teknologian Tutkimuskeskus VTT Oy provides technology solutions and innovation services. It offers its services in the sectors of bioeconomy, health and wellbeing, digital society, sustainable city, low carbon energy, technology industry, business development, and research infrastructure. The company was founded on January 16, 1942 and is headquartered in Espoo, Finland.

Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI.

Finnvera Oyj is a financing company that provides financing for the start-up, growth, and internationalization of enterprises and for protection against export risks. Its products include loans, domestic guarantees, export credit guarantees, venture capital investments, export credits, and interest equalization. The company was founded on July 9, 1998 and is headquartered in Kuopio, Finland.

Part of Amrop International, Hever Group is a British company that provides headhunting services. The company is based in London, UK. Hever Group was acquired by Amrop International on June 15, 2000.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ.

Veraventure Oy is a venture capital investment firm based in Kuopio, Finland. Established in 2003, they are a wholly-owned subsidiary of Finnvera Oy. Veraventure is responsible for the management and development of the parent firm's investments linked to regional funds. Finnvera is a specialized financing firm, owned and operated by the Finnish Government and supervised by the Ministry of Trade and Industry. Veraventure specializes in complementing regional markets in equity financing. They have a particular focus on early-stage financing as well as providing capital related to generational changes and for small and mid-size firms. They are the investment manager of the Seed Fund Vera. The firm also has offices in Oulu and Helsinki, Finland.

Lundbeck Ltd. engages in the research, development, production, marketing and sale of pharmaceuticals. It provides services that aid in the treatment of CNS disorders, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia. The company was founded in 1972 and is headquartered in St. Albans, the United Kingdom.

Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom.

Nokia International Oy provides telecommunications and network equipment products and services. It also offers applications, games, music, media, digital map information and navigation services. The company is headquartered in Uusimaa, Finland.

Part of Roche Holding AG, Roche Diagnostics Oy is a Finnish biotechnology company that specializes in in vitro diagnostics. The company is based in Espoo, Finland. RochePRO service provides healthcare professionals with up-to-date information on upcoming events and training, as well as materials for patient care. Roche Diagnostics was founded in 2005. The CEO is Matheus Barbosa Vieira.

National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD.

Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland.

Miradore Oy operates as a software company which specializes in providing cloud-based solutions for managing information technology devices. It offers Miradore Online, a cloud-based Mobile Device Management (MDM) solution that safeguards company’s data and devices. The firm also provides hardware and software asset management, operating system and software deployment, patch management, endpoint backup, and remote assistance and control. The company was founded by Mika Liukko and Paul Palojärvi in 2006 and is headquartered in Lappeenranta, Finland.

Analyse Solutions Finland Oy provides custom-made assortment solutions for retailers and suppliers. It develops software tool that combines product attributes and consumer trends to help companies in the fast moving consumer goods business build the optimal assortment. The company was founded by Janne Mikael Anttila and Kari Pekka Erämaa in 2004 and is headquartered in Espoo, Finland.

MK Ventures ApS provides investment services. The private company is based in Copenhagen, Denmark. The Danish company was founded by Marko Kuisma and he has been the CEO since incorporation.

The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles.

M-Files Oy provides enterprise information management software solutions. It eliminates information silos and provides quick and easy access to the right content from any core business system and device. The company was founded by Mikko Nivala on November 25, 1987 and is headquartered in Tampere, Finland.

VividWorks Oy provides software solutions. It offers online 3D design-to-purchase Software-as-a-Service platform, which enable visual customization of products as a part of the purchase experience. The company was founded by Miska Tuomas Visuri, Henrikki Poika Saraspaa, and Jani Parviainen in 2006 and is headquartered in Oulu, Finland.

Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014.

Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland.

Maplet Oy provides internet mapping services. Its products include locator map, field sales map and custom solutions. The company was founded in 2013 and is headquartered in Helsinki, Finland.

Meles Consulting Oy provides management consulting services. The private company is based in Espoo, Finland. The CEO of the Finnish company is Pekka Ilmari Simula.

Alex Therapeutics AB is a digital therapeutics company that partners with pharmaceutical companies to create and license digital therapies. The company is based in Stockholm, Sweden and was founded by Oliver Fleetwood, John Drakenberg Renander. The Swedish company has a proven "Alex DTX Platform" and expertise in patient-centric design and evidence-based psychology. The company has clinically validated products and overwhelmingly positive patient and partner testimonials. Alex combines cognitive behavioral therapy and AI for behavioral change.

HVR Cardio Oy is a Finnish cardiovascular device company that is developing breakthrough solutions for mitral valve repair based on its proprietary helix technology. The company is based in Espoo, Finland. The company's lead products, CathHELIX® and MAR®, are transcatheter and surgical mitral valve repair devices that are designed to be faster, easier to use, and less invasive without compromising clinical efficacy. The company was founded by Olli Urho Tapani Keränen, and Tom Fleming has been the CEO of the company since 2022.

Nanocomp Oy Ltd. designs and manufactures micro- and nanophotonics solutions. It develops thin foil optics. The firm offers service from design to tooling and mass production of micro- and nanoscale surface structures. It products and services is use for displays; three-dimensional sensing/gesture recognition; laser measuring; wearable devices; and healthcare application. The company was founded by Veli-Pekka Leppänen in 1997 and is headquartered in Lehmo, Finland.